Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidancePilling, S., Mayo-Wilson, E., Mavranezouli, I., Kew, K. M., Taylor, C., Clark, D. M., Afgan, S., Anigbogu, B., Armstrong, P., Bennett, M., Cartwright-Hatton, S., Creswell, C., Dix, M., Hanlon, N., Leggett, K., Malizia, A. L., Roberts, J., Satrettin, K., Stephens, G., Stockton, S. and Stopa, L. (2013) Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance. British Medical Journal, 346. f2541. ISSN 1468-5833
It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing. To link to this item DOI: 10.1136/bmj.f2541 Abstract/SummarySocial anxiety disorder is one of the most persistent and common of the anxiety disorders, with lifetime prevalence rates in Europe of 6.7% (range 3.9-13.7%).1 It often coexists with depression, substance use disorder, generalised anxiety disorder, panic disorder, and post-traumatic stress disorder.2 It can severely impair a person’s daily functioning by impeding the formation of relationships, reducing quality of life, and negatively affecting performance at work or school. Despite this, and the fact that effective treatments exist, only about half of people with this condition seek treatment, many after waiting 10-15 years.3 Although about 40% of those who develop the condition in childhood or adolescence recover before adulthood,4 for many the disorder persists into adulthood, with the chance of spontaneous recovery then limited compared with other mental health problems. This article summarises the most recent recommendations from the National Institute for Health and Care Excellence (NICE) on recognising, assessing, and treating social anxiety disorder in children, young people, and adults.5
Download Statistics DownloadsDownloads per month over past year Altmetric Deposit Details University Staff: Request a correction | Centaur Editors: Update this record |